Cisplatin and capecitabine
WebCisplatin is a platinum-based agent whose nephrotoxicity is thought related to the chloride in the cis position. Cisplatin gains entry into tubular cells via uptake by the OCT-2 … WebJan 19, 2024 · In the second-line setting, the ABC-06 trial of 162 patients with advanced biliary tract cancer demonstrated a significant, albeit modest, survival benefit for oxaliplatin-based combination therapy versus active symptom control alone after failure of an initial cisplatin/gemcitabine regimen (median 6.2 versus 5.3 months) [ 2 ].
Cisplatin and capecitabine
Did you know?
WebJun 23, 2014 · This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients after curative intent resection of BTC. Detailed Description: WebJun 23, 2024 · Days 1-14: Capecitabine 1,000mg/m 2 orally twice daily. Repeat cycle every 3 weeks. Capecitabine + Cisplatin (Category 2B) 26,a,f. Day 1: Cisplatin 60mg/m 2 IV …
WebOct 6, 2014 · New first-line regimens demonstrated equivalence (epirubicin, cisplatin, and capecitabine [ECX]; epirubicin, oxaliplatin, and capecitabine [EOX]; and mFOLFOX) or … WebThe primary goal of the study was to investigate whether capecitabine and oxaliplatin are at least as effective as fluorouracil and cisplatin, respectively, in terms of overall survival. Other...
WebConclusions: Epirubicin, cisplatin, and capecitabine seems to be active in platinum-resistant relapsed EOC with manageable toxicity. Further prospective investigation of platinum-anthracycline combinations is warranted in patients who relapse 3 to 6 months after first-line platinum-taxane treatment. Publication types Clinical Trial MeSH terms WebApr 6, 2024 · V.; et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): A randomised, open-label phase 3 trial. Lancet Oncol .
WebMay 8, 2024 · The ACTICCA-1 study initially explored the use of adjuvant gemcitabine and cisplatin after surgery compared with surveillance alone. With the results of BILCAP, however, ACTICCA-1 amended the control arm to include adjuvant capecitabine. SWOG is planning an adjuvant study in North America as well, Dr. Shroff said.
how do i clear my browser cookiesWebApr 11, 2024 · Patients will be treated with anlotinib, penpulimab and capecitabine every three weeks until PD or intolerance to toxicity. ... He X, Zhang B, Yang Q, Zhang X, Zou J, Fang W, Zhang L. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma … how much is number one copperWebSep 15, 2024 · Cisplatin Injection (cisplatin injection (cisplatin (cisplatin injection) injection) ) is a sterile aqueous solution, available in 50, 100 and 200 mL multiple dose … how much is nursing schoolWebMar 15, 2024 · Trastuzumab plus fluorouracil and cisplatin; FOLFOX plus trastuzumab; Capecitabine and oxaliplatin (CAPOX) plus trastuzumab; Concurrent … how much is nurtecWebUsually you have a combination of 2 or 3 drugs (in a regimen). Your oncologist will explain which regimen they think is best for you. The most common types are: fluorouracil, folinic acid, oxaliplatin and docetaxel (FLOT) epirubicin, cisplatin and capecitabine (ECX) epirubicin, cisplatin and fluorouracil (ECF) how do i clear my browser history in edgeWebCombination of platinum compounds such as cisplatin or oxaliplatin with fluoropyrimidines such as 5-fluorouracil (5-FU) or capecitabine remains the mainstay of standard first-line therapy for gastric cancer improving overall survival (OS) to about 9–11 months. 6–8 Therefore, there is a need for targeted treatments and pathway-driven ... how much is nursing home feesWebIn this study, neoadjuvant chemotherapy with the triplet regimen of albumin-bound paclitaxel with cisplatin and capecitabine (APCC regimen) for locally advanced resectable ESCC showed high anti-tumor activities and significant effect on tumour downstaging. None of the evaluable patients (n=30) had disease progression after chemotherapy. how do i clear my browsing history on msn